Sweet Earth Holdings Corporation

Sweet Earth Holdings Corporation cultivates, processes, and sells hemp cannabidiol (CBD) products in the United States and Spain. The company offers CBD and hemp infused facial products, including CBD hydration creams, oat and honey cleansers, and soothing CBD lip balms; and botanicals and essential oils, such as balancing CBD jasmine oils, soothing CBD bath salt soaks, invigorating CBD neem and turmeric scrubs, and aloe-infused CBD hand sanitizers for body and skin care. It also provides beard and face care products for men comprising CBD face cleansers, shaving creams, aftershave creams, beard and face oils, and styling balms; hemp products; CBD pre-rolls; and CBD dog treats consisting of garbanzo, flour, potato flakes, cheddar cheese, full spectrum hemp oil, natural beef flavor, MCT coconut oil, and mixed tocopherols. The company is based in Vancouver, Canada.

Sweet Earth Holdings Corporation trades as SEHCF on OTC. The company is classified in Healthcare / Drug Manufacturers - Specialty & Generic and reports in USD.

The current profile places the business in Drug Manufacturers - Specialty & Generic. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Sweet Earth Holdings Corporation can be compared against peers such as Avant Brands Inc., Blueberries Medical Corp., Trees Corporation, Captiva Verde Wellness Corp., Mountain Valley MD Holdings Inc., Rapid Nutrition PLC.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $6.44M, beta of 1.16, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

SEHCF currently shows total debt of N/A and beta of 1.16. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://sweetearthskincare.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.